Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9603 |
High Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.9281 |
High Similarity |
NPD1934 |
Approved |
0.8994 |
High Similarity |
NPD6959 |
Discontinued |
0.8882 |
High Similarity |
NPD1511 |
Approved |
0.8854 |
High Similarity |
NPD2801 |
Approved |
0.8827 |
High Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8827 |
High Similarity |
NPD6166 |
Phase 2 |
0.8827 |
High Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8766 |
High Similarity |
NPD1512 |
Approved |
0.8734 |
High Similarity |
NPD7819 |
Suspended |
0.8704 |
High Similarity |
NPD6232 |
Discontinued |
0.8701 |
High Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8667 |
High Similarity |
NPD5844 |
Phase 1 |
0.8662 |
High Similarity |
NPD4380 |
Phase 2 |
0.8659 |
High Similarity |
NPD7473 |
Discontinued |
0.8625 |
High Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8625 |
High Similarity |
NPD3882 |
Suspended |
0.8614 |
High Similarity |
NPD7074 |
Phase 3 |
0.8609 |
High Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.8609 |
High Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.858 |
High Similarity |
NPD5494 |
Approved |
0.8571 |
High Similarity |
NPD7075 |
Discontinued |
0.8562 |
High Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.8554 |
High Similarity |
NPD7054 |
Approved |
0.8553 |
High Similarity |
NPD1549 |
Phase 2 |
0.8503 |
High Similarity |
NPD7472 |
Approved |
0.85 |
High Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8494 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.8462 |
Intermediate Similarity |
NPD2533 |
Approved |
0.8462 |
Intermediate Similarity |
NPD2534 |
Approved |
0.8462 |
Intermediate Similarity |
NPD2532 |
Approved |
0.8452 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.8447 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.8402 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.8344 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8301 |
Intermediate Similarity |
NPD2796 |
Approved |
0.8294 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.8272 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.8261 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.8246 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.8246 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.8235 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.8228 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.8225 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.8224 |
Intermediate Similarity |
NPD1607 |
Approved |
0.821 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.8199 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.8194 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.8129 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.8117 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.8092 |
Intermediate Similarity |
NPD1240 |
Approved |
0.8065 |
Intermediate Similarity |
NPD6099 |
Approved |
0.8065 |
Intermediate Similarity |
NPD6100 |
Approved |
0.805 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.805 |
Intermediate Similarity |
NPD6799 |
Approved |
0.8047 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.8025 |
Intermediate Similarity |
NPD2800 |
Approved |
0.8025 |
Intermediate Similarity |
NPD3226 |
Approved |
0.8013 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7975 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7974 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7974 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7974 |
Intermediate Similarity |
NPD943 |
Approved |
0.7966 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7964 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7952 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7929 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7929 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7904 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7888 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.7881 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7877 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7862 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7834 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7834 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7829 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7806 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7799 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7784 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7784 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7784 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7778 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7772 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7771 |
Intermediate Similarity |
NPD37 |
Approved |
0.7771 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7765 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7751 |
Intermediate Similarity |
NPD919 |
Approved |
0.775 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7746 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7738 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7738 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7738 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7697 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7683 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7674 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7662 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7661 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7658 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7644 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7643 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7632 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7627 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7616 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7613 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7613 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7598 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7581 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7581 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7581 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7581 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7581 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7581 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7581 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7578 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7578 |
Intermediate Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.7576 |
Intermediate Similarity |
NPD920 |
Approved |
0.7572 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7561 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7561 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7556 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7547 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7514 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD4360 |
Phase 2 |
0.75 |
Intermediate Similarity |
NPD4363 |
Phase 3 |
0.75 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7484 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.747 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.746 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7455 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7453 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7439 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7414 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7391 |
Intermediate Similarity |
NPD5405 |
Approved |
0.7391 |
Intermediate Similarity |
NPD5408 |
Approved |
0.7391 |
Intermediate Similarity |
NPD5406 |
Approved |
0.7391 |
Intermediate Similarity |
NPD5404 |
Approved |
0.7389 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7389 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7386 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7371 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.7371 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.7368 |
Intermediate Similarity |
NPD7698 |
Approved |
0.7368 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.7368 |
Intermediate Similarity |
NPD7697 |
Approved |
0.7368 |
Intermediate Similarity |
NPD1201 |
Approved |
0.7368 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7368 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7363 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7362 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.7358 |
Intermediate Similarity |
NPD447 |
Suspended |
0.733 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.733 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.7321 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7317 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7316 |
Intermediate Similarity |
NPD6823 |
Phase 2 |
0.7312 |
Intermediate Similarity |
NPD6535 |
Approved |
0.7312 |
Intermediate Similarity |
NPD6534 |
Approved |
0.7306 |
Intermediate Similarity |
NPD7701 |
Phase 2 |
0.7296 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7294 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.729 |
Intermediate Similarity |
NPD1470 |
Approved |
0.7289 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7278 |
Intermediate Similarity |
NPD1699 |
Clinical (unspecified phase) |
0.7278 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7278 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7273 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7273 |
Intermediate Similarity |
NPD2309 |
Approved |
0.725 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7247 |
Intermediate Similarity |
NPD7177 |
Discontinued |
0.7234 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7231 |
Intermediate Similarity |
NPD7874 |
Approved |
0.7231 |
Intermediate Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.7222 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7212 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7202 |
Intermediate Similarity |
NPD6273 |
Approved |
0.7197 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7197 |
Intermediate Similarity |
NPD9494 |
Approved |
0.7196 |
Intermediate Similarity |
NPD7700 |
Phase 2 |
0.7196 |
Intermediate Similarity |
NPD7699 |
Phase 2 |
0.7194 |
Intermediate Similarity |
NPD7801 |
Approved |
0.7182 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7181 |
Intermediate Similarity |
NPD4361 |
Phase 2 |
0.7181 |
Intermediate Similarity |
NPD4362 |
Clinical (unspecified phase) |
0.7179 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7171 |
Intermediate Similarity |
NPD1651 |
Approved |
0.717 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7165 |
Intermediate Similarity |
NPD7584 |
Approved |
0.7161 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7152 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7143 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7143 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7134 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7134 |
Intermediate Similarity |
NPD1471 |
Phase 3 |
0.7117 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7115 |
Intermediate Similarity |
NPD1283 |
Approved |
0.711 |
Intermediate Similarity |
NPD5761 |
Phase 2 |
0.711 |
Intermediate Similarity |
NPD5760 |
Phase 2 |
0.711 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7108
|
Intermediate Similarity |
NPD8166 |
Discontinued |